Join our community book club. The Los Angeles Times Book Club hosts conversations with your favorite authors and newsmakers ...

The Catholic Church, under the late Pope Francis, said in 2022 that ESG investing is consistent with the Church’s values. More than 1,500 employees already are working on the project, says its owner.

John Cena has put over a lot of talent, but not always. We dive into the controversial stories of 5 WWE superstars like Wade ...

Bishop Dyer hopes his run in NXT as Baron Corbin is more fondly remembered over time. Dyer recently spoke with WrestleZone Managing Editor Bill Pritchard about his WWE tenure, and if there’s one thing ...

- Announced positive topline data from Phase 2 trial in chronic spontaneous urticaria; results showed ozureprubart at both Q8W and Q12W dosing had comparable efficacy and safety to omalizumab at Q4W ...

Presented new preclinical data on INB-619, a novel gamma-delta (γδ) T cell engager (TCE), demonstrating equivalent potency comparable to FDA-approved commercial products with minimal adverse cytokine ...

MORRISTOWN, N.J., Nov. 6, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver ...

Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use estimated glomerular filtration rate (eGFR) slope as an endpoint to ...

New Delhi [India], November 6 (ANI): The resurgence of gold as a principal reserve asset highlights a major transformation in the global financial system, according to a report by CareEdge Ratings. As ...

- Initiated prestIgE Phase 2b trial of ozureprubart in food allergy - Announced positive topline data from Phase 2 trial in chronic spontaneous urticaria; results showed ozureprubart at both Q8W and ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-reports-third-quarter-2025-financial-results-and-recent ...